OrganoBiotech
PrivateCompany Overview
OrganoBiotech is a biotechnology company that develops organ-on-a-chip platform technologies and automated 3D tissue models to accelerate drug discovery.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
organ-on-a-chip3D tissue culturedrug discoverypreclinical testinghigh-throughput screeningMPSmicrophysiological systemsdisease modelinglab-on-a-chipperfusion systemcontract researchCROAI drug discoverybiotech equipmentin vitro models
Historical Pricing
Historical view of private secondary pricing and transaction trends.
OrganoBiotech Comparables
Compare OrganoBiotech with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AIM Biotech | 87% | |
| BiomimX | 87% | |
| AlveoliX AG | 86% | |
OrganoBiotech Funding Rounds
Historical fundraising activity
OrganoBiotech Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Canadian Institutes of Health Research | Grant |
| Stem Cell Network | Grant |
| Canada Foundation for Innovation | Grant |
| Natural Sciences and Engineering Research Council of Canada | Grant |
| McMaster University | Grant |
OrganoBiotech Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about OrganoBiotech's valuation, stock price, and market status.